Serum triglycerides and mortality risk across stages of chronic kidney disease in 2 million U.S. veterans
- 1 September 2019
- journal article
- research article
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 13 (5) , 744-753.e15
Abstract
No abstract availableKeywords
Funding Information
- Department of Veterans Affairs
- Veterans Health Administration
- Office of Research and Development
- Health Services Research and Development
This publication has 40 references indexed in Scilit:
- Effects of blood triglycerides on cardiovascular and all-cause mortality: a systematic review and meta-analysis of 61 prospective studiesLipids in Health and Disease, 2013
- Association between triglycerides and cardiovascular events in primary populations: a meta-regression analysis and synthesis of evidenceVascular Health and Risk Management, 2013
- Serum triglycerides and risk for death in Stage 3 and Stage 4 chronic kidney diseaseNephrology Dialysis Transplantation, 2012
- Validating Smoking Data From the Veteran's Affairs Health Factors Dataset, an Electronic Data SourceNicotine & Tobacco Research, 2011
- Hyperlipidemia and Long-Term Outcomes in Nondiabetic Chronic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2010
- Fasting Compared With Nonfasting Triglycerides and Risk of Cardiovascular Events in WomenJAMA, 2007
- Veterans Aging Cohort Study (VACS)Medical Care, 2006
- Cardiovascular Mortality Risk in Chronic Kidney DiseaseJAMA, 2005
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationNew England Journal of Medicine, 2004
- Lipid and Apolipoprotein Profiles of Uremic Dyslipoproteinemia -Relation to Renal Function and DialysisNephron, 1991